IGM Biosciences, Inc. held its 2024 annual meeting of stockholders, where directors were elected, appointment of independent registered public accounting firm was ratified, approval of a certificate of amendment to the company's certificate of incorporation was granted, and a stock option exchange program for employees was approved.